FIELD OF definition

FIELD OF. USE shall mean all therapeutic applications related to the delivery of proteins/pepides or oligonucleotides/nucleic acids, including but not limited to genes.
FIELD OF. RESEARCH shall mean the development of zinc finger DNA binding proteins and nucleic acids that encode zinc finger DNA binding proteins for the activation of VEGF and VEGF receptors for the treatment and prevention of ischemic cardiovascular and vascular disease in humans.
FIELD OF. Use shall mean any use.

Examples of FIELD OF in a sentence

  • FIELD OF APPLICATIONThis method is applicable, after removal of non-fibrous matter, to binary fibre mixtures of: 1.

  • LICENSOR MAKES NO REPRESENTATION AS TO WHETHER ANY CLAIM OR PATENT WITHIN PATENT RIGHTS IS VALID, OR AS TO WHETHER THERE ARE ANY PATENTS NOW HELD, OR WHICH WILL BE HELD, BY OTHERS OR BY LICENSOR THAT MIGHT BE REQUIRED FOR USE OF PATENT RIGHTS IN FIELD OF USE.

  • MY GOAL IS TO HELP YOU DISCOVER YOUR ABILITY TO MAXIMIZE YOUR TRAINING AND BECOME SUCCESSFUL IN THE FIELD OF BEAUTY.

  • YOU ARE NOW ENTERING INTO A FIELD OF EDUCATION THAT WILL MOST LIKELY PROVIDE YOU WITH THE OPPORTUNITY AND SKILLS FOR A SUCCESSFUL FUTURE IN THE BEAUTY INDUSTRY.

  • FIELD OF aPPLICaTION This method is applicable, after removal of non-fibrous matter, to binary fibre mixtures of: 1.

  • ORGANIZATION, CHARTERING AND FIELD OF MEMBERSHIP OF A CREDIT UNION 189—2.1(533) Definitions.

  • FIELD OF APPLICATIONThis method is applicable, after removal of non-fibrous matter, to binary mixtures of:1.

  • I explained that we were confident that we could mitigate risk for you and could ensure that you would have no contact with other people while you were at work.

  • FIELD OF APPLICATIONThis method is applicable, after removal of non-fibrous matter, to binary fibre mixtures of:1.

  • For latest information refer towww.ilac.org and www.iaf.nu where listings of current regional members of ILAC and IAF are available 6.7.2. THE IMPACT ON TRADE RELATIONS IN THE FIELD OF CONFORMITY ASSESSEMNT BETWEEN THE EU AND THIRD COUNTRIES‌ The ultimate acceptance of conformity assessment attestations is decided by the public authorities in the regulatory sphere and, from an economic point of view, by industry users and consumers.


More Definitions of FIELD OF

FIELD OF. USE As defined in the Option Agreement; provided that any BTK inhibitors discovered under the Sponsored Research Agreement with NeuPharma funded by TGTX, the Field of Use shall not be restricted and shall include all uses under the License Agreement. DIRECT SALES ROYALTIES *% royalties on Net sales > $* *% royalties on Net sales >$* but <$* *% royalties on Net Sales >$* * Confidential material redacted and filed separately with the Commission. MILESTONE PAYMENTS TO FORTRESS The following amounts within 20 days of the following milestones: Upon Exercise of Option: $* 1: $* – * 2: $* – * 3: $* – * 4: $* on * 5: $* on * 6: $* on * 7: $* on * 8: $* on * 9: $* on * Milestones 2-7 above shall be payable one time for any Product (including RX518) primarily targeting EGFR. For any Product primarily targeting BTK, Milestones 2-7 shall be payable for each of the first three Indications for which Product achieves the respective Product Milestone Event. * Confidential material redacted and filed separately with the Commission. RESPONSIBILITIES OF THE PARTIES The parties shall share the costs of all IND-Enabling work 50/50. IND-Enabling costs shall include, without limitation, all pre-clinical toxicology, pharmacology, CMC, and other work required for the filing of an IND. These costs shall include only external costs incurred and each party shall be responsible for internal costs (personnel, overhead, etc.) incurred in connection with the IND filing. Each party shall pay the costs of filing their own IND and thereafter, TG shall be responsible for 100% of the clinical development, drug supply, and commercialization costs and expenses of developing the Compounds in the Field. Parties shall share CMC and formulation development costs. TG shall pay individually for any specific experiments that relate solely to the BTK properties of the Compounds. Any Compounds that target BTK and are derived from the sponsored research by TG, TG shall be responsible for the full costs of development and commercialization and will have full worldwide rights to these Compounds under the License Agreement. GOVERNING LAW The Collaboration Agreement shall be governed by the laws of the State of New York without regard to principals of conflicts of law thereof. Other Provisions The Agreement would also contain additional customary terms and conditions agreed by the Parties.
FIELD OF. Use shall mean all applications of the Sublicensed Technology, except applications for use as Light Sources operating in the DUV, Extreme UV, VUV, and Soft X-ray wavelengths of the spectrum for Lithography (defined below), Metrology (defined below) and/or […***…] applications (defined below).
FIELD OF. USE shall mean Light Sources operating in the DUV, EUV, VUV and Soft X-ray wavelengths of the spectrum for Lithography, Metrology and [...***...] applications.

Related to FIELD OF

  • Field of Use means all fields of use.

  • Licensed Field of Use means all fields.

  • Field of vision means the section of the tri-dimensional space above ground level which is monitored with the help of a device for indirect vision. Unless otherwise stated, this is based on the view offered by a device and/or devices other than mirrors. This may be limited by the relevant detection distance corresponding to the test object.

  • Licensed Field means all fields of use.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Product Technology means the following information owned by or to the extent licensed to Seller, as in existence and in the possession of Seller as of the Closing Date: the manufacturing technology, proprietary or confidential information, processes, techniques, protocols, methods, improvements and know-how that are necessary to manufacture the Products in accordance with the current applicable Product ANDA, as the case may be, including, but not limited to, the manufacturing process approved in the applicable Product ANDAs, specifications and test methods, raw material, packaging, stability and other applicable specifications, manufacturing and packaging instructions, master formula, validation reports to the extent available, stability data, analytical methods, records of complaints, annual product reviews to the extent available, and other master documents necessary for the manufacture, control and release of the Products as conducted by, or on behalf of, Seller or any of its Affiliates before the Effective Date. The Product Technology includes without limitation the rights owned or to the extent controlled by Seller under any patent issued in or subject to a pending application in the Territory as of the Closing Date, and any rights under any patent or patent application outside of the Territory solely to the extent necessary to manufacture the Products outside the Territory for importation to and sale in the Territory.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Licensor Technology means the Licensor Patents and the Licensor Know-How.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Joint Technology means the Joint Know-How and the Joint Patent Rights.

  • Field of Interest means the research, development, manufacture and/or sale of the products resulting from the Company’s technology. The limitations on competition contained in this Section 8 shall continue during the time that Xxxxxxxx performs any Services for the Company, and for a period of three (3) months following the termination of any such Services that Xxxxxxxx performs for the Company. If any part of this section should be determined by a court of competent jurisdiction to be unreasonable in duration, geographic area, or scope, then this Section 8 is intended to and shall extend only for such period of time, in such area and with respect to such activity as is determined to be reasonable. Except as expressly provided herein, nothing in this Agreement shall preclude Xxxxxxxx from consulting for or being employed by any other person or entity.

  • New Technology means any invention, discovery, improvement, or innovation that was not available to the District on the effective date of the contract, whether or not patentable, including, but not limited to, new processes, emerging technology, machines, and improvements to or new applications of existing processes, machines, manufactures and software. Also included are new computer programs, and improvements to, or new applications of, existing computer programs, whether or not copyrightable and any new process, machine, including software, and improvements to, or new applications of, existing processes, machines, manufactures and software.

  • Developed Technology means Proprietary Rights that (a) are first generated, conceived or reduced to practice, as the case may be, by Allergan or by any third party in the course of performing activities undertaken pursuant to the Research and Development Agreement or (b) are, in any manner, acquired by, or otherwise obtained on behalf of, ASTI during the term of the Research and Development Agreement from persons other than Allergan and are necessary or useful to the research, development or commercialization of ASTI Products or Pre-Selection Products.

  • Biological Materials means certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company.

  • Third Party Technology means all Intellectual Property and products owned by third parties and licensed pursuant to Third Party Licenses.

  • Field means the general area underlaid by one or more pools.

  • Cannabis products means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Exclusive Field means the diagnosis, treatment or prevention of any cancer in humans through the use of Engineered T-Cells, which shall exclude the diagnosis, treatment or prevention of medullary cystic kidney disease 1 regardless of whether such disease is characterized as a cancer.

  • Commercialize means to engage in Commercialization.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Licensed Patents means the patent applications and patents listed in Exhibit A, together with any and all substitutions, extensions, divisionals, continuations, continuations-in-part (to the extent that the claimed subject matter of a continuation-in-part is disclosed and enabled in the parent patent application and is not, as of the Effective Date, obligated to a third party), foreign counterparts of such patent applications in the Licensed Territory, and any and all patents that issue on any one or more of those in the Licensed Territory including reexamined and reissued patents.

  • Biological Material means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;